Quellthera

Quellthera is a company developing circumventing antibiotic resistance with therapies that stop bacteria from producing toxins. It offers EpiQuell, a concept in anti-pathogenic therapies that harnesses the plant kingdom’s evolution-proven ability to control bacterial behavior.